LEV PHARMACEUTICALS

lev-pharmaceuticals-logo

Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008, Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.

#SimilarOrganizations #People #Financial #More

LEV PHARMACEUTICALS

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2003-01-01

Address:
New York, New York, United States

Country:
United States

Total Employee:
11+

Status:
Active

Total Funding:
41 M USD


Similar Organizations

resolvyx-pharmaceuticals-logo

Resolvyx Pharmaceuticals

Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.

Current Employees Featured

not_available_image

Joshua D. Schein
Joshua D. Schein Co-founder @ Lev Pharmaceuticals
Co-founder

ira-kalfus_image

Ira Kalfus
Ira Kalfus Vice President @ Lev Pharmaceuticals
Vice President

judson-a-cooper_image

Judson A. Cooper
Judson A. Cooper Co-founder @ Lev Pharmaceuticals
Co-founder

Founder


not_available_image

Joshua D. Schein

judson-a-cooper_image

Judson A. Cooper

Investors List

mast-capital-management_image

Mast Capital Management

Mast Capital Management investment in Venture Round - Lev Pharmaceuticals

alexandra-investment-management_image

Alexandra Investment Management

Alexandra Investment Management investment in Venture Round - Lev Pharmaceuticals

rosalind-capital-partners_image

Rosalind Capital Partners

Rosalind Capital Partners investment in Venture Round - Lev Pharmaceuticals

emigrant-capital_image

Emigrant Capital

Emigrant Capital investment in Venture Round - Lev Pharmaceuticals

southpoint-capital-advisors_image

Southpoint Capital Advisors

Southpoint Capital Advisors investment in Venture Round - Lev Pharmaceuticals

hound-partners_image

Hound Partners

Hound Partners investment in Venture Round - Lev Pharmaceuticals

More informations about "Lev Pharmaceuticals"

Lev Pharmaceuticals 2025 Company Profile: Valuation, Investors ...

Information on acquisition, funding, investors, and executives for Lev Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

ViroPharma To Acquire Lev Pharmaceuticals - Fierce Biotech

Jul 15, 2008 The acquisition of Lev Pharmaceuticals further enhances ViroPharma's pipeline with Cinryze (TM) (C1 inhibitor (human)), which is currently under regulatory review for โ€ฆSee details»

Lev Pharmaceuticals - Ownership and Business Overview - Mergr

Oct 21, 2008 Lev Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases.See details»

Lev Pharmaceuticals - Funding, Financials, Valuation & Investors

Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.See details»

Lev Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Lev Pharmaceuticals was a Healthcare/Pharmaceuticals / Drugs company based in New York, New York. Use the CB Insights Platform to explore Lev Pharmaceuticals's full profile.See details»

Lev Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical trials ...

Explore Lev Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Immune System Diseases, Technology Platform ...See details»

Lev Pharmaceuticals, Inc. (Lev Pharmaceuticals, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ โ€ฆ

May 1, 2023 About Lev Pharmaceuticals, Inc. Lev is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases.See details»

Lev Pharmaceuticals, Inc.:Company Profile & Technical Research ...

Lev Pharmaceuticals is a company that provides Medicine, Pharmacy and Therapeutics, Hereditary angioedema and more. Lev Pharmaceuticals is headquartered in United States โ€ฆSee details»

Joshua Schein - CEO - Lev Pharmaceuticals | LinkedIn

CEO at Lev Pharmaceuticals · Experience: Lev Pharmaceuticals · Location: New York. View Joshua Scheinโ€™s profile on LinkedIn, a professional community of 1 billion members.See details»

ViroPharma To Acquire Lev Pharmaceuticals

Jul 16, 2008 ViroPharma Incorporated and Lev Pharmaceuticals, Inc. recently announced that the companies have signed a definitive merger agreement under which ViroPharma will โ€ฆSee details»

ViroPharma Inc. (VPHM) and Lev Pharmaceuticals Inc. (LEVP.OB) โ€ฆ

Jul 15, 2008 Biopharmaceutical companies ViroPharma Inc. (Nasdaq: VPHM) and Lev Pharmaceuticals Inc. (OTCBB: LEVP) today announced a definitive merger agreement โ€ฆSee details»

ViroPharma Incorporated Completes Acquisition Of Lev โ€ฆ

Oct 24, 2008 ViroPharma Incorporated recently announced it has completed its acquisition of Lev Pharmaceuticals following the approval earlier today of the transaction by Lev stockholders.See details»

Lev Pharmaceuticals Company Profile | Management and

Find contact information for Lev Pharmaceuticals. Learn about their Drug Stores & Pharmacies, Retail market share, competitors, and Lev Pharmaceuticals's email format.See details»

ViroPharma to buy Lev for $442M | Fierce Biotech

Jul 15, 2008 ViroPharma has forged a deal to buy Lev Pharmaceuticals - a developer focused on developing inflammatory therapies -- for $442 million. The deal provides ViroPharma with โ€ฆSee details»

Lev Pharmaceuticals - Overview, News & Similar companies

View Lev Pharmaceuticals (www.levpharm.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

What is Lev Pharmaceuticals? Company Culture, Mission, Values

See what employees say it's like to work at Lev Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Lev Pharmaceuticals.See details»

Lev Pharmaceuticals - Crunchbase

Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.See details»

Paladin Pharma and the pan-Canadian Pharmaceutical Alliance โ€ฆ

56 minutes ago Paladin Pharma Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical โ€ฆSee details»

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense ...

Mar 10, 2025 Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Companyโ€™s Single-Dose Mpox and Smallpox โ€ฆSee details»

Lev Pharmaceuticals - Contacts, Employees, Board Members

Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.See details»

linkstock.net © 2022. All rights reserved